Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05843500 · ClinicalTrials.gov registry record
Chronic Thromboembolic Disease Registry
A clinical trial of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05843500 is a study of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 767-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05843500, a study of Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question\[s\] it aims to answer are: * Long-term outcome after various types of treatment, including medication, balloon pulmonary angioplasty, and pulmonary endarterectomy * Effect of treatment on patient's quality of life and exercise tolerance Participants will be followed longitudinally to assess their health outcomes and quality of life via chart review and health quality surveys.
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2028-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05843500
The ClinicalTrials.gov registry entry for NCT05843500 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 767-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (87% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Thromboembolic Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT05843500 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05843500 about?
NCT05843500 is a clinical study titled "Chronic Thromboembolic Disease Registry". The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question\[s\] it aims to answer are: * Long-term outcome after various types of treatment, including m...
What is the current status of trial NCT05843500?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-08-01. Estimated completion is 2028-07-01.
What conditions does trial NCT05843500 study?
This clinical trial studies the following conditions: Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Disease.
What interventions are being tested in trial NCT05843500?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05843500?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05843500 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Thromboembolic Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Pulmonary Hypertension Biorepository and Registry
RECRUITING
-
Pulmonary Hypertension Association Registry
RECRUITING
-
TrEatment Approach in the Multimodal Era Registry
ACTIVE NOT RECRUITING
-
Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Explore more on PlainTrial
Chronic Thromboembolic Pulmonary Hypertension
All registered trials for this condition
Chronic Thromboembolic Disease
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.